Skip to main content


The deal

Investing in a leading consolidation platform in the UK and Irish SME professional services market


Deal size, May 2022

Fund IV

Current investment

The teams

Management Team

Chair: Alastair Marsh

CEO: Derry Crowley

The story

Xeinadin is the UK’s leading provider of accountancy services and business advice for SMEs. It operates from over 100 locations across the UK and Ireland and serves over 50,000 clients.

Exponent is investing alongside the management team and practice leaders. We are partnering with the incumbent team, led by CEO Derry Crowley and Chair Alastair Marsh. Exponent Operating Partner John Dwyer also sits on the board.

Exponent’s investment will support Xeinadin’s growth ambitions, both organically and through acquisitions. It will also enable investment in innovative data-driven technologies, which will drive efficiencies and improve the quality, breadth and delivery of services to its clients.

We were attracted to the business by its sticky and resilient customer base, transformational opportunity presented by technology and regulation, and the significant M&A opportunity that exists in the market.